CLDF Title
Home | Contact Us | Bookmark
 
 
About CLDF Centers of Educational Expertise  
 
Back Hepatology Centers of Educational Expertise
Banner
 
Dr. Gish
Dr. Gish began his medical training in 1974 when he was enrolled into the Pharmacy School at the University of Kansas. Dr. Gish transferred to the University of Kansas Medical School in 1977 and finished his MD degree in 1980. Dr. Gish went on to complete a 3 year Internal Medicine residency at the University of California, San Diego and a 4 year Gastroenterology and Hepatology fellowship at the University of California Los Angeles during which time he was award the NIH Physician Scientist Award to study calcium signaling in liver cells.

After completing his training, Dr. Gish moved to San Francisco and took a position at the California Pacific Medical Center (formerly known as Pacific Presbyterian Hospital). He became the Co-Medical Director of the Liver Transplant Program in 1988 and then the Medical Director of the Liver Transplant Program in 1994. In that role he developed a outreach program that eventually served over 35,000 patients in the Northern California and Nevada regions, and made the CPMC a leading liver transplant center.

  More
 
  Ask the Expert 
Ask a Question
 
  CME and Independent Education  
 
   
 
 
 
  Physician Resources 
 
 
  My Links  
 
  St Joseph's Liver Website
 
  HB Foundation Website
 
  National Viral Hepatitis Roundtable Website
 
  RobertGish.com Website
 
 
  My Publications More  
 
  Current Treatment Guidelines for Chronic Hepatitis B and Their Applications.
 
  Letter to California Technology Assessment Forum
 
  Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery.
 
  Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
 
  One-step real-time PCR assay for detection and quantitation of hepatitis D virus RNA
 
 
  Disease Educational Content  
 
  Video Lecture - CIRRHOSIS (LIVER SCARRING) by Dr. Robert Gish
  Video Lecture - TIPSS by Dr. Robert Gish
  Video Lecture - LIVER BIOPSY by Dr. Robert Gish
  Video Lecture - LIVER & NUTRITION IN CIRRHOSIS by Dr. Robert Gish
  Video Lecture - HEPATITIS C (HCV) by Dr. Robert Gish
  Video Lecture - HEPATITIS B (HBV) by Dr. Robert Gish
  Video Lecture - NASH (FATTY LIVER) by Dr. Robert Gish
  Video Lecture - BENIGN (NON-CANCEROUS) LIVER TUMORS by Dr. Robert Gish
  Video Lecture - AUTOIMMUNE HEPATITIS by Dr. Robert Gish
  Video Lecture - LIVER CANCER, HEPATOCELLULAR CARCINOMA, AND HEPATOMA by Dr. Robert Gish
   
  Abnormal Liver Tests: work-up and diagnosis
  HCV: management of the patient with Cirrhosis: a focus on treatment
  Don't interfere! My first choice is always nucs.
  HCV – Treat now!
  Cirrhosis and Coagulation A Paradigm of Awareness 2014
  Current Therapy of Hepatitis B Planning for 2014 and beyond - SOTA 2014
  Hepatitis E: E is for Elusive
  The HCV Treatment Revolution: A view from the Community Health Center
  State of the Art Therapy for HCV
   
   
  Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases
  Educational eNewsletter
   
   
  Hepatic Encephalopathy: A Review of Diagnostic Methods
  Educational eNewsletter
   
   
  Hepatic Encephalopathy Update: Prophylactic Therapy to Prevent Hepatic Encephalopathy
  Educational eNewsletter
   
   
   
 
  Institution Information
Dr. Gish formed the medical consulting firm Robert G. Gish Consultants LLC in 2013 to assist liver and liver transplant programs with their operational, outreach, compliance, financial planning and program development. His firm also provides consultations with Pharma and a means of interaction between the pharmaceutical industry and CME organizations in addition to promoting liver health policies throughout the world.

 
 
Current Studies  
Institution Link  
 
     
 
Liver News - REUTERS
 
  Novo Nordisk and Gilead team up to test fatty liver disease treatment  
  04-12-2019  
     
  Clusters of autoimmune liver disease suggest environmental trigger  
  04-11-2019  
     
  US liver cancer deaths more common with less education  
  04-08-2019  
     
  Fecal microbiome signature detects cirrhosis in nonalcoholic fatty-liver disease  
  04-04-2019  
     
  View Complete News Library  
  Line  
  Journal Abstracts  
  Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries  
     
  Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis  
     
  Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs  
     
  Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs  
     
  Vitamin D deficiency and health-related quality of life in chronic hepatitis C  
     
  Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience  
     
  View All Articles  
  Line  
  Congress Calendar  
     
  View All Conventions  
     
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.